Stéphane Bancel (AP Images)
August 6, 2021 06:15 AM EDTUpdated 06:33 AM
Deals
Bioregnum

mGx M&A? Mod­er­na ex­ecs are lever­ag­ing their Covid cash on gene edit­ing, gene ther­a­py deals

Mod­er­na’s lit­tle busi­ness deal with Au­to­lus ear­li­er this week looks like a predin­ner snack ahead of the main course to come.

Dur­ing his Q2 …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

Where the mon­ey is: The top 100 ven­ture in­vestors in biotech

Trump’s sci­ence crack­down hits rare dis­ease re­search: ‘We need to sit down with Elon Musk’

Bi­par­ti­san 'pill penal­ty' fix and oth­er bills vie for in­clu­sion in rec­on­cil­i­a­tion pack­age

Can Bill An­der­son save Bay­er?

Post-Hoc: Phar­ma CEOs' al­ter­na­tive re­al­i­ty with Trump

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times